Note: Ingredients listed on restricted chemical lists
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
**
EC/CAS
200-711-8/69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
*
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
*
General Information
Version
1.0
Revision date
2010-02-18
Product name
Zoledronic Acid Injection
Product name
Zoledronic Acid Injection
Identification on the label/Trade name
Not applicable
Chemical name
Bisphosphonate
1.2.1 Relevant identified uses
Pharmaceutical product
Emergency telephone
1-800-424-9300, +44 (0)208 762 8322
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Appearance Clear, colorless solution
Signal word
DANGER
Hazard statements
May damage fertility or the unborn child.
Additional information
Known Clinical Effects Common adverse effects include nausea, vomiting, gastrointestinal irritation, fatigue, decreased red blood cell count (anemia), constipation, fever, shortness of breath (dyspnea), and bone pain. EU Indication of danger Toxic to reproduction, Category 2 EU Hazard Symbols EU Risk Phrases R60 - May impair fertility. R61 - May cause harm to the unborn child. Australian Hazard Classification (NOHSC): Note
Hazardous Ingredients
Non-Dangerous Goods This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
